期刊文献+
共找到282篇文章
< 1 2 15 >
每页显示 20 50 100
Comparison of UV/PDS and UV/H_2O_2 processes for the degradation of atenolol in water 被引量:4
1
作者 Xiaowei Liu Lei Fang +2 位作者 Yongchao Zhou Tuqiao Zhang Yu Shao 《Journal of Environmental Sciences》 SCIE EI CAS CSCD 2013年第8期1519-1528,共10页
UV/H2O2 and UV/peroxodisulfate (PDS) processes were adopted to degrade a typical β-blocker atenolol (ATL). The degradation efficiencies under various operational parameters (oxidant dosage, pH, HCO3-, humic acid... UV/H2O2 and UV/peroxodisulfate (PDS) processes were adopted to degrade a typical β-blocker atenolol (ATL). The degradation efficiencies under various operational parameters (oxidant dosage, pH, HCO3-, humic acid (HA), NO3- , and Cl-) were compared. Principal factor analysis was also performed with a statistical method for the two processes. It was found that increasing the specific dosage of the two peroxides ([peroxide]0/[ATL]0 ) ranging from 1:1 to 8:1 led to a faster degradation rate but also higher peroxide residual. Within the pH range 3-11, the optimum pH was 7 for the UV/PDS process and elevating pH benefitted the UV/H 2O2 process. The presence of HCO3- , HA, and Cl adversely affected ATL oxidation in both processes. The NO3- concentration 1-3 mmol/L accelerated the destruction of ATL by the UV/PDS process, but further increase of NO3- concentration retarded the degradation process, contrary to the case in the UV/H2O2 process. The rank orders of effects caused by the six operational parameters were pH ≈ specific dosage 〉 [HA]0 〉 [NO3-]0 〉 [HCO3-]0 〉 [Cl-]0 for the UV/H2O2 process and specific dosage 〉 pH 〉 [HA]0 〉 [NO3-]0 〉 [HCO3-]0 〉[Cl-]0 for the UV/PDS process. The UV/PDS process was more sensitive to changes in operational parameters than the UV/H2O2 process but more efficient in ATL removal under the same conditions. 展开更多
关键词 sulfate radical hydroxyl radical atenolol influencing factors rank order
原文传递
Controlled Drug Release Studies of Atenolol Using Differently Sulfonated Acryloxyacetophenone and Methyl Methacrylate Copolymer Resins as Drug Carriers 被引量:2
2
作者 K.Doraswamy P.Venkata Ramana 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2014年第3期280-291,共12页
2-Acryloxyacetophenone (AAP) was prepared and subjected to suspension polymerization with methyl methacrylate (MMA) using azobisisobutyronitrile (AIBN) as free radical initiator. The differently sulfonated AAP-M... 2-Acryloxyacetophenone (AAP) was prepared and subjected to suspension polymerization with methyl methacrylate (MMA) using azobisisobutyronitrile (AIBN) as free radical initiator. The differently sulfonated AAP-MMA cross-linked copolymer cationic exchange resins were prepared by sulfonation with concentrated sulphuric acid at 70 ~C. Several characteristics of the prepared resins were evaluated, i.e. FTIR, the ion-exchange capacity (IEC), thermo gravimetric analysis (TGA), particle size distribution and microscopic morphology. The resin characteristics were altered with degree of sulfonation, providing that differently sulfonated resins could be prepared. The behavior of atenolol (ATL) loading and in vitro release in the USP stimulated gastric and intestinal fluids of the obtained resins were evaluated. The drug loaded in the resin increased with increasing degree of sulfonation and hence the drug binding site in resin employed. The drug release was lower from the resins with higher content of sulfonic group due to the increase in the diffusive path depth. The drug release was a little lower in stimulated gastric fluid (SGF) than in stimulated intestinal fluids (SIF). The basic groups, ionized to a little greater extent in SGF and preferred binding with the resin rather than releasing. Hence, the differently sulfonated resins could be utilized as novel carriers for drug delivery. 展开更多
关键词 2-Acryloxyacetophenone Methyl methacrylate Different sulfonation Cationic exchange resins atenolol In vitro drug release.
原文传递
Spectrophotometric Methods for Simultaneous Determination of Amlodipine Besylate and Atenolol in Their Tablet Dosage Form 被引量:1
3
作者 Nesrine T.Lamie 《光谱学与光谱分析》 SCIE EI CAS CSCD 北大核心 2015年第12期3538-3543,共6页
Three simple,specific,accurate and precise spectrophotometric methods are developed for simultaneous determination of amlodipine besylate(AM)and atenolol(AT)in tablets.The first method is dual wavelength spectrophotom... Three simple,specific,accurate and precise spectrophotometric methods are developed for simultaneous determination of amlodipine besylate(AM)and atenolol(AT)in tablets.The first method is dual wavelength spectrophotometry(DW).The second method is ratio subtraction(RS)which depends on subtraction of the plateau values from the ratio spectrum,coupled to first derivative of ratio spectra(1 DD).The third method applies bivariate calibration method using 210and 225nm as an optimum pair of wavelength for amlodipine and atenolol.The calibration curves are linear over the concentration range of 4~40μg·mL-1 for both drugs.The specificity of the developed methods is investigated by analyzing laboratory prepared mixtures of the two drugs and their combined dosage form.The two methods are validated as per ICH guidelines and can be applied for routine quality control testing. 展开更多
关键词 AMLODIPINE atenolol RATIO SUBTRACTION Dual wavelength Derivative-ratio BIVARIATE Spectro-photometry
在线阅读 下载PDF
Quantitative Application to a Polypill by the Development of Stability Indicating LC Method for the Simultaneous Estimation of Aspirin, Atorvastatin, Atenolol and Losartan Potassium 被引量:1
4
作者 Satheesh K. Shetty Koduru V. Surendranath +4 位作者 Pullapanthula Radhakrishnanand Roshan M. Borkar Prashant S. Devrukhakar Johnson Jogul Upendra M. Tripathi 《American Journal of Analytical Chemistry》 2010年第2期59-69,共11页
Polypill is a fixed-dose combination (FDC) containing three or more drugs in a single pill with the intention of reducing the number of tablets or capsules that need to be taken. Developing a single analytical method ... Polypill is a fixed-dose combination (FDC) containing three or more drugs in a single pill with the intention of reducing the number of tablets or capsules that need to be taken. Developing a single analytical method for the estimation of individual drugs in a Polypill is very challenging, due to the formation of drug-drug and drug-excipients interaction impurities. Here an attempt was made to develop a new, sensitive, single stability-indicating HPLC method for the simultaneous quantitative determination of Aspirin (ASP) Atorvastatin (ATV), Atenolol (ATL) and Losartan potassium (LST) in a polypill form in the presence of degradation products. Efficient chromatographic separation was achieved on a C18 stationary phase with simple mobile phase combination of buffer and Acetonitrile. Buffer consists of 0.1% Orthophosphoric acid (pH 2.9), delivered in a gradient mode and quantitation was carried out using ultraviolet detection at 230 nm with a flow rate of 1.0 mL/min. The retention times of Atenolol, Aspirin, Losartan potassium, and Atorvastatin were 3.3, 7.6, 10.7 and 12.9 min respectively. The combination drug product are exposed to thermal, acid/base hydrolytic, humidity and oxidative stress conditions, and the stressed samples were analyzed by proposed method. The method was validated with respect to linearity;the method was linear in the range of 37.5 to 150.0 μg/mL for ASP, 5.0 to 20.0 μg/mL for ATV and 25.0 to 100.0 μg/mL for ATL and LST. Acceptable precision and accuracy were obtained for concentrations over the standard curve ranges. The validated method was successfully applied to the analysis of Starpill tablets constituting all the four drugs;the percentage recoveries obtained were 99.60% for ASP, 99.30% for ATV, 99.41% for ATL and 99.62% for LST. 展开更多
关键词 Liquid Chromatography POLYPILL ASPIRIN ATORVASTATIN atenolol and LOSARTAN Potassium FORCED Degradation Validation Stability Indicating
暂未订购
Synthesis and Spectroscopic Characterizations on the Complexation of Three Different Metal Ions Ba(Ⅱ),Ni(Ⅱ),and Ce(Ⅲ)with Atenolol Drug Chelate
5
作者 Samy M El-Megharbel Tariq Altalhi +1 位作者 Abdullah Ayad Salem Alruqi Moamen S Refat 《光谱学与光谱分析》 SCIE EI CAS CSCD 北大核心 2020年第6期1988-1992,共5页
Three types of metal ions barium(Ⅱ),nickel(Ⅱ)and cerium(Ⅲ)complexity of ATN drug have been prepared and characterized using molar conductance method,FT-IR,electronic,and 1H-NMR analysis measurements.The chemical an... Three types of metal ions barium(Ⅱ),nickel(Ⅱ)and cerium(Ⅲ)complexity of ATN drug have been prepared and characterized using molar conductance method,FT-IR,electronic,and 1H-NMR analysis measurements.The chemical and physical results for all atenolol complexes are agreement with the speculated structures.For the divalent(Ba&Ni)and trivalent(Ce)metal atenolol a molar ratio 1∶2 was established.Qualitative chemical analysis showed that for the divalent metal complexes,the chloride ions are not involved in the complexes,suggesting that all of these complexes,[Ba(ATN)2]·2 H2O and[Ni(ATN)2(H2O)2]·4 H2O are neutral.However,for the cerium(Ⅲ)complex,[Ce(ATN)2(NO3)]·3 H2O,the nitrate group is existed inside the coordination sphere.ATN make astable metal complexity with barium(Ⅱ),nickel(Ⅱ)and cerium(Ⅲ)ions.Electronic absorption analysis of Atenolol give two fundamental peaks at 225 nm and 274 nm refers to variation in transition electrons of ligand,UV spectral analysis of the three complexity obtained give asymmetric broad band in the range 200~400 nm,the reults are convenient with the suggestion of metal-nitrogen and metal-oxygen bonds.The infrared analysis data proved that ATN act as bidentate ligand through the N atom of the-NH group and O atom of the deprotonated alcoholic OH group.Nickel(Ⅱ)and cerium(Ⅲ)complexity make six-coordinate geometry,whereas the barium(Ⅱ)complex exhibit four-coordinate geometry.Ni(Ⅱ)-ATN complex has an effective magnetic moment equal 3.12 B.M,that is assigned to octahedral structure.The 1H-NMR spectral results of Ba(Ⅱ)-ATN complexity give strong signal at^4.00 ppm due to protons of-CH2 that influenced by low degree due to complexity.These results confirm the position of chelation through the N atom of the-NH group and O atom of the deprotonated alcoholic OH group. 展开更多
关键词 atenolol DRUG Metal IONS COMPLEXATION
在线阅读 下载PDF
Kinetics Study on Reaction of Atenolol with Singlet Oxygen by Directly Monitoring the^(1)O_(2)Phosphorescence
6
作者 Chen Wang Ming-chen Xiong +1 位作者 Xuan Zhao Kun-hui Liu 《Chinese Journal of Chemical Physics》 SCIE CAS CSCD 2021年第4期406-412,I0002,共8页
The pharmaceuti-cally active com-pound atenolol,a kind of β-blockers,may result in ad-verse effects both for human health and ecosystems if it is excreted to the surface water resources.To e ectively remove atenolol ... The pharmaceuti-cally active com-pound atenolol,a kind of β-blockers,may result in ad-verse effects both for human health and ecosystems if it is excreted to the surface water resources.To e ectively remove atenolol in the environ-ment,both direct and indirect photodegradation,driven by sunlight play an important role.Among indirect photodegradation,singlet oxygen(^(1)O_(2)),as a pivotal reactive species,is likely to determine the fates of atenolol.Nevertheless,the kinetic information on the re-action of atenolol with singlet oxygen has not been well investigated and the reaction rate constant is still ambiguous.Herein,the reaction rate constant of atenolol with singlet oxy-gen is investigated directly through observing the decay of the^(1)O_(2)phosphorescence at 1270 nm.It is determined that the reaction rate constant between atenolol and^(1)O_(2)is 7.0×10^(5)(mol/L)^(-1)·s^(-1)in D2O,8.0×10^(6)(mol/L)^(-1)·s^(-1)in acetonitrile,and 8.4×10^(5)(mol/L)^(-1)·s^(-1)in EtOH,respectively.Furthermore,the solvent effects on the title reaction were also inves-tigated.It is revealed that the solvents with strong polarity and weak hydrogen donating ability are suitable to achieve high rate constant values.These kinetics information on the reaction of atenolol with singlet oxygen may provide fundamental knowledge to the indirect photodegradation of β-blockers. 展开更多
关键词 atenolol Rate constant Singlet oxygen Time resolved spectroscopy
在线阅读 下载PDF
Transdermal Formulation Development and Topical Administration of Atenolol to Cats
7
作者 Sumeia M. Mohamed John Mark Christensen Nicole LeBlanc 《Pharmacology & Pharmacy》 2020年第3期39-53,共15页
Atenolol diffusion through synthetic membrane, cloned human epidermis, and cat ear skin was performed utilizing a Franz diffusion cell. Transdermal drug diffusion enhancers’ ethanol, glycerol, propylene glycol, polys... Atenolol diffusion through synthetic membrane, cloned human epidermis, and cat ear skin was performed utilizing a Franz diffusion cell. Transdermal drug diffusion enhancers’ ethanol, glycerol, propylene glycol, polysorbate 80 and Dimethyl isosorbide (DMI) were added to the topical formulations and tested for their ability to enhance drug permeation through the test membranes. Topical formulation with penetration enhancers showed a rapid burst of atenolol diffusion for the first two hours (35.5 to 40 μg/ml) followed by a zero-order sustained diffusion of 2.7 μg/cm2/h of atenolol for up to twenty-four hours after application to test membranes. Increased atenolol flux through different test membranes was greatest for synthetic membrane. The topical application of the optimized atenolol formulation to cat skin containing permeation enhancers aided transdermal atenolol drug delivery to treat cats with hypertrophic obstructive cardiomyopathy. The optimum topical formulation demonstrated two fluxes through cat skin, the burst flux (15.7 μg/cm2/h) and a sustained flux (2.7 μg/cm2/h). Measured atenolol concentrations in cats at 3, 6 and 12 hours after transdermal atenolol application were 432.7 ng/ml ± 323.3, 262.4 ng/ml ± 150.1, and 253.3 ng/ml ± 133.6 respectively. Six of 7 cats achieved therapeutic serum atenolol levels (260 ng/ml) for at least one time point. Five of 7 cats had therapeutic serum atenolol concentrations 3 hours post-atenolol. At the 6 hours post-atenolol time point, only 2 had a therapeutic serum atenolol concentration while at 12 hours post-atenolol dosing, 4 of 7 cats had therapeutic serum atenolol concentrations. Transdermal atenolol administered at 25 mg q12h resulted in clinically therapeutic serum atenolol concentrations in the majority of healthy cats. The optimum transdermal formulation enabled good drug delivery feasible for transdermal application in a clinical trial in cats. 展开更多
关键词 atenolol TRANSDERMAL Delivery FORMULATION CATS
在线阅读 下载PDF
Effect of Tebuconazole exposure on oral Atenolol absorption in rats,based on bile acid homeostasis
8
作者 TAO Quan XU Yu-jing +4 位作者 ZHANG Yu-feng TAO Yu-chen ZHUANG Xu-zhen YIN Deng-ke YANG Ye 《Journal of Hainan Medical University》 CAS 2023年第7期15-22,共8页
Objective:This study is aimed to explore the effect of triazole fungicide tebuconazole(TEB)exposure on the oral absorption behavior of atenolol(AT),based on the homeostasis of bile acids(BAs).Methods:TEB was daily gav... Objective:This study is aimed to explore the effect of triazole fungicide tebuconazole(TEB)exposure on the oral absorption behavior of atenolol(AT),based on the homeostasis of bile acids(BAs).Methods:TEB was daily gavaged to rats with 3 mg/kg dose for 28 days to establish the TEB-exposure rat model.The amounts of glycocholic acid,glycochenodeoxycholic acid,taurocholic acid and taurine deoxycholic acid in the small intestine contents of normal and TEB-exposure rats were detected by LC-MS/MS.AT(10 mg/kg)were gavaged to the normal and TEB-exposure rats,and then blood were collected from orbital venous plexus at predetermined time-points.The concentration of AT in plasma was detected by LC-MS/MS,and the pharmacokinetic parameters were calculated by the DAS pharmacokinetic software.An intestinal circulation perfusion model was established in normal rats,and perfused with the perfusates containing the model drug of fluorescein and the BAs with the same compositions as the normal/TEB-exposure rats.After perfusion,the absorption and permeability of fluorescein in intestine were detected,as well as the oxidative stress status and ZO-1 expression level in the intestinal tissues.Results:Compared with normal rats,TEB-exposure increased the amounts of glycocholic acid,glycochenodeoxycholic acid,taurocholic acid and taurine deoxycholic acid in intestine significantly(P<0.001).In TEB-exposure rats,the maximum plasma concentration and area under the curve of AT were increased significantly than those of normal rats(P<0.05),and the peak time was significantly delayed(P<0.05).The TEB-induced BAs homeostasis perturbance increased intestinal permeability,and this effect was associated with the elevation of oxidative stress and the down-regulation of intercellular tight junction proteins in intestinal tissues.Conclusion:TEB-exposure can affect the oral absorption behavior of AT,which is probably related with the intestinal BAs homeostasis perturbance,thus it might affect the clinical efficacy and safety of this drug. 展开更多
关键词 TEBUCONAZOLE atenolol Bile acids PHARMACOKINETICS Tight junction protein Oxidative stress
暂未订购
Synthesis and Modification of Carboxylated Multi Wall Nanotubes with Atenolol
9
作者 Sajjad Sedaghat 《Soft Nanoscience Letters》 2014年第3期75-81,共7页
In this paper functionalized multiwall carbon nanotubes (FMWCNT) were modified using atenolol as a class of drugs that were used in cardiovascular diseases containing reactable nitrogen, which could attach chemically ... In this paper functionalized multiwall carbon nanotubes (FMWCNT) were modified using atenolol as a class of drugs that were used in cardiovascular diseases containing reactable nitrogen, which could attach chemically to functionalized MWCNT. This product was characterized by Fourier transform infrared spectroscopy (FT-IR) and Raman spectroscopy. These spectrums proved the existence of nitrogen atoms of amide due to new functional group. The morphology were also determined by scanning electron microscopy (SEM) and showed that this product was synthesized in the nanometer dimension. Thermal gravimetery (TGA) analysis was also used to evaluate thermal properties. 展开更多
关键词 atenolol Functinalized Multiwalled Carbon NANOTUBES MODIFICATION MORPHOLOGY SEM
在线阅读 下载PDF
Drug-Drug Interaction Studies of Levocetirizine with Atenolol
10
作者 Shafaque Mehboob Muhammad Azhar Mughal +3 位作者 Khalid Aftab MoonaMehboob Khan Najma Sultana Syed Arayne 《Journal of Pharmacy and Pharmacology》 2017年第3期118-124,共7页
The objective of the study was to evaluate the drug-drug interaction studies of levoceterizine with atenolol. Calibration curve studies of working standard solutions of levocetirizine and atenolol (0.01-0.1 mmol) we... The objective of the study was to evaluate the drug-drug interaction studies of levoceterizine with atenolol. Calibration curve studies of working standard solutions of levocetirizine and atenolol (0.01-0.1 mmol) were scanned. Maxima appeared at 231 nm for levocetirizine and 224 nm for atenolol. The calibration curve obeyed Beer Lambert's Law. Lone availabilities of both the drugs were studied in pH 1, pH 4, pH 7.4 and pH 9 at 37℃ on B.P. (British Pharmacopoeia) dissolution apparatus. To study the drug-drug interaction of levocetirizine (5 mg tablet) and atenolol (100 mg tablet), both the drugs were introduced to the dissolution apparatus in simulated gastric juice (pH 1), pH 4, pH 7.4 and pH 9 at 37℃ at zero time and measured the absorbance maxima of both the drugs at the corresponding wavelength. Graphs were plotted for availability percentage (%) of drug versus time at each set of experiment. The availability percentage (%) of levocetirizine in the buffers of pH simulated to gastric pH 4, pH 7.4 and pH 9 in the presence of atenolol was 436.78%, 376.90%, 436.78% and 436.78%, respectively, but the availability of atenolol was increased up to 214.80%, 212.96%, 214.93% and 231.51% in simulated to gastric pH and in the buffers ofpH 4, pH 7.4 and pH 9, respectively. On the basis of these studies, it is concluded that levocetirizine forms a charge-complex with atenolol; therefore, co-administration of these drugs should be avoided. 展开更多
关键词 LEVOCETIRIZINE atenolol drug-drug interactions absorbance maxima.
在线阅读 下载PDF
Atenolol与Captopril合用治疗舒张性心衰临床观察
11
作者 秦富吉 《中国冶金工业医学杂志》 1995年第6期355-356,共2页
Atenolol与Captopril合用治疗舒张性心衰临床观察秦富吉莱芜钢铁总厂医院(271126)关键词Atenolol,Captopril,心衰近年来心衰的病理生理学取得了较大进展,明确了左室收缩功能不全和舒张功... Atenolol与Captopril合用治疗舒张性心衰临床观察秦富吉莱芜钢铁总厂医院(271126)关键词Atenolol,Captopril,心衰近年来心衰的病理生理学取得了较大进展,明确了左室收缩功能不全和舒张功能不全的区别,认识到有些疾病单因舒... 展开更多
关键词 atenolol CAPTOPRIL 舒张性心力衰竭 联合用药
暂未订购
水中β受体阻滞剂类心血管药物污染研究进展
12
作者 王倩 李青云 +3 位作者 何灿 王梦玉 李久义 张忠国 《环境科学与技术》 北大核心 2025年第1期118-126,共9页
随着心血管药物使用量的逐年上升,各种环境介质中已普遍检测到心血管药物的存在。由于其生物累积性与潜在毒性,如何有效控制水中心血管类药物污染物及评估其生态风险是目前研究的热点。文章以β受体阻滞剂为典型心血管药物,主要阐述其... 随着心血管药物使用量的逐年上升,各种环境介质中已普遍检测到心血管药物的存在。由于其生物累积性与潜在毒性,如何有效控制水中心血管类药物污染物及评估其生态风险是目前研究的热点。文章以β受体阻滞剂为典型心血管药物,主要阐述其在环境中的分布、迁移、转化和生态毒性,目前已在各类环境样品中检测到多达12种β受体阻滞剂,相关研究多集中于废水和地表水,地下水中的研究较少。文章总结了其污染控制技术,提出重点研究方向:(1)加强不同环境基质中的监测、深入调查其在中国不同地区的环境分布状况;(2)深入研究β受体阻滞剂的代谢途径、代谢物及其生态效应,以及混合药物的协同生物学效应,以期为水中心血管药物的治理和风险控制提供参考。 展开更多
关键词 受体阻滞剂 阿替洛尔 生态毒性 心血管药物
原文传递
选择性β1受体阻滞剂治疗高血压的有效性与安全性Meta分析
13
作者 尚予淇 张志勇 +1 位作者 王惠铎 郭浩 《中国医院药学杂志》 北大核心 2025年第9期1035-1045,共11页
目的:分析选择性β_(1)受体阻滞剂治疗高血压的有效性和安全性,进一步更新选择性β_(1)受体阻滞剂的循证医学证据。方法:计算机检索中国知网(CNKI)、万方(Wanfang)、维普(VIP)、中国生物医学文献服务系统(SinoMed)、PubMed、Embase、Coc... 目的:分析选择性β_(1)受体阻滞剂治疗高血压的有效性和安全性,进一步更新选择性β_(1)受体阻滞剂的循证医学证据。方法:计算机检索中国知网(CNKI)、万方(Wanfang)、维普(VIP)、中国生物医学文献服务系统(SinoMed)、PubMed、Embase、Cochrane Library,搜集关于选择性β_(1)受体阻滞剂治疗高血压患者的随机对照试验,检索时间均为建库至2024年5月。由两名研究者独立进行文献进行筛选、提取资料并评估纳入研究的偏倚风险,采用Cochrane偏倚风险工具对纳入研究进行质量评价,采用R4.4.0软件进行网状Meta分析,计算各结局指标的累积排序概率图下面积(the surface under the cumulative ranking,SUCRA)以比较不同干预措施的有效性与安全性。结果:SUCRA值排序结果显示,在降低收缩压方面:比索洛尔(79.33%)>阿替洛尔(57.46%)>美托洛尔缓释剂(51.12%)>美托洛尔速释剂(12.08%);降低舒张压方面:压比索洛尔(77.38%)>阿替洛尔(65.63%)>美托洛尔缓释剂(51.41%)>美托洛尔速释剂(5.57%);降低24 h动态收缩压方面:比索洛尔(92.44%)>美托洛尔速释剂(54.09%)>美托洛尔缓释剂(52.47%)>阿替洛尔(1.01%);降低24 h动态舒张压方面:比索洛尔(95.24%)>美托洛尔速释剂(52.52%)>美托洛尔缓释剂(46.82%)>阿替洛尔(5.4%);降低心率幅度方面:比索洛尔(97.88%)>阿替洛尔(66.98%)>美托洛尔缓释剂(22.72%)>美托洛尔速释剂(12.42%);降低24 h动态心率方面:美托洛尔缓释剂(69.49%)>比索洛尔(54.97%)>阿替洛尔(39.39%)>美托洛尔速释剂(36.17%);不良反应发生率方面:阿替洛尔(81.38%)>美托洛尔缓释剂(54.86%)>比索洛尔(48.97%)>美托洛尔速释剂(14.79%)。结论:比索洛尔、阿替洛尔、美托洛尔速释剂和美托洛尔缓释剂治疗高血压时均有明显的有效性,其中比索洛尔的有效性最为显著,而阿替洛尔的总不良反应发生率较高,临床使用时应给予关注。 展开更多
关键词 β_(1)受体阻滞剂 比索洛尔 美托洛尔 阿替洛尔 有效性与安全性 网状Meta分析
原文传递
参松养心胶囊联合阿替洛尔片对冠心病合并心律失常患者的治疗效果观察
14
作者 郭一博 汤有为 《药品评价》 2025年第5期536-539,共4页
目的探讨参松养心胶囊联合阿替洛尔片对冠心病合并心律失常患者的疗效,以期为临床早期制定干预治疗方案提供参考依据。方法回顾性选取南阳医学高等专科学校第一附属医院2021年3月至2024年3月就诊的92例冠心病合并心律失常患者,根据治疗... 目的探讨参松养心胶囊联合阿替洛尔片对冠心病合并心律失常患者的疗效,以期为临床早期制定干预治疗方案提供参考依据。方法回顾性选取南阳医学高等专科学校第一附属医院2021年3月至2024年3月就诊的92例冠心病合并心律失常患者,根据治疗方案不同分为研究组、对照组,各46例。两组均给予常规治疗,对照组给予阿替洛尔片治疗,研究组在对照组基础上联合参松养心胶囊治疗,两组均连续治疗4周。比较两组临床疗效,治疗前后心律失常发作次数,心功能指标[左室射血分数(LVEF)、心脏指数(CI)、心肌肌钙蛋白I(cTnI)],血管弹性指标[臂踝脉搏波传导速度(baPWV)、颈股动脉脉搏波传导速度(cfPWV)、踝肱指数(ABI)]及治疗期间不良反应发生情况。结果与对照组相比,研究组总有效率95.65%较高(P<0.05);治疗后,研究组心律失常发作次数较对照组低(P<0.05);治疗后,研究组LVEF、CI较对照组高,cTnI较对照组低(P<0.05);治疗后,研究组baPWV、cfPWV较对照组低,ABI较对照组高(P<0.05);两组治疗期间不良反应发生率比较差异无统计学意义(P>0.05)。结论参松养心胶囊联合阿替洛尔片对于冠心病合并心律失常疗效显著,可有效促进心功能及血管弹性改善,减少心律失常发作次数,且用药安全性良好。 展开更多
关键词 冠心病 心律失常 参松养心胶囊 阿替洛尔片 治疗效果
暂未订购
不同β受体阻滞剂治疗婴幼儿血管瘤的疗效观察
15
作者 王涛 刘昌荣 +5 位作者 邓立才 王倩 高居辉 陈世恭 陈新弟 林向上 《临床小儿外科杂志》 CAS CSCD 北大核心 2024年第2期168-172,共5页
目的分析不同β受体阻滞剂治疗婴幼儿血管瘤的临床疗效和并发症,观察治疗期间药物对生长发育的影响。方法本研究为前瞻性研究,选取2017年1月至2022年5月福建医科大学附属福州儿童医院烧伤整形科采用口服β受体阻滞剂治疗的33例婴幼儿血... 目的分析不同β受体阻滞剂治疗婴幼儿血管瘤的临床疗效和并发症,观察治疗期间药物对生长发育的影响。方法本研究为前瞻性研究,选取2017年1月至2022年5月福建医科大学附属福州儿童医院烧伤整形科采用口服β受体阻滞剂治疗的33例婴幼儿血管瘤病例作为研究对象,其中男14例,女19例。按照患儿家属意愿分为普萘洛尔组(22例)和阿替洛尔组(11例),普萘洛尔组予口服非选择性β受体阻滞剂(普萘洛尔),剂量为1.5~2 mg·kg^(-1)·d^(-1)。阿替洛尔组予口服选择性β受体阻滞剂(阿替洛尔),剂量为第1周0.5 mg·kg^(-1)·d^(-1),之后改为1 mg·kg^(-1)·d^(-1)。两组均每月复查1次,观察瘤体颜色、大小、质地等变化及并发症情况;分别于用药后1个月、5~6个月、10~12个月通过彩超测量瘤体体积,并进行生长发育评估。结果两组患儿首诊年龄、性别、部位、类型等差异无统计学意义(P>0.05)。两组患儿治疗有效率均为100%。两组用药后1个月、5~6个月、10~12个月瘤体体积缩小差异无统计学意义(P>0.05)。不良反应:普萘洛尔组有5例(5/22)出现呼吸道症状、烦躁或睡眠障碍;阿替洛尔洛尔组有2例(2/11)出现烦躁或睡眠障碍;两组均无一例严重不良反应,生长发育均未发现异常,用药后1、3、6、9个月发育商比较,差异亦无统计学意义(P>0.05)。结论β受体阻滞剂普萘洛尔与阿替洛尔治疗婴幼儿血管瘤疗效相当,对患儿生长发育均无影响。考虑普萘洛尔对呼吸道有不良影响,阿替洛尔可作为普萘洛尔的替代药物用于治疗婴幼儿血管瘤。 展开更多
关键词 血管瘤 普萘洛尔 阿替洛尔 治疗结果 药物相关性副作用和不良反应 儿童发育
暂未订购
宣痹通脉汤联合阿替洛尔治疗急性心肌梗死气虚血瘀证的临床研究
16
作者 朱小志 《四川生理科学杂志》 2024年第6期1295-1296,1394,共3页
目的:探讨急性心肌梗死(Acute myocardial infarction,AMI)气虚血瘀证患者采用宣痹通脉汤联合阿替洛尔治疗的临床效果。方法:纳入2021年1月至2022年12月在本院接受治疗的70例AMI气虚血瘀证患者。随机将其分为对照组与观察组,各35例。对... 目的:探讨急性心肌梗死(Acute myocardial infarction,AMI)气虚血瘀证患者采用宣痹通脉汤联合阿替洛尔治疗的临床效果。方法:纳入2021年1月至2022年12月在本院接受治疗的70例AMI气虚血瘀证患者。随机将其分为对照组与观察组,各35例。对照组采用阿替洛尔治疗;观察组在对照组基础上联合宣痹通脉汤治疗。分析比较两组中医证候评分、心功能指标、治疗期间不良反应发生情况。结果:治疗后,观察组症候评分较对照组显著降低(P<0.05)。治疗后,观察组各项心功能指标水平较对照组显著提高(P<0.05)。两组不良反应发生率无显著差异。结论:宣痹通脉汤联合阿替洛尔治疗AMI气虚血瘀证可改善患者心功能,缓解临床症状,且安全性较好。 展开更多
关键词 急性心肌梗死 气虚血瘀证 宣痹通脉汤 阿替洛尔 心功能 不良反应
暂未订购
离子对色谱法分离氨基醇类对映体 被引量:20
17
作者 徐秀珠 邹莉 +1 位作者 胡明华 邵保海 《分析化学》 SCIE EI CAS CSCD 北大核心 2001年第11期1295-1298,共4页
运用离子对色谱法 ,以 (+) 10 樟脑磺酸为手性离子对试剂 ,在二醇柱 (Lichrospher 10 0 DIOL)上 ,分离了苯丙醇胺、美托洛尔、普萘洛尔、肾上腺素和沙丁胺醇 5种氨基醇类对映体。考察了流动相组成和化合物结构对分离选择性的影响。... 运用离子对色谱法 ,以 (+) 10 樟脑磺酸为手性离子对试剂 ,在二醇柱 (Lichrospher 10 0 DIOL)上 ,分离了苯丙醇胺、美托洛尔、普萘洛尔、肾上腺素和沙丁胺醇 5种氨基醇类对映体。考察了流动相组成和化合物结构对分离选择性的影响。选用的流动相为二氯甲烷 正戊醇 (97 3、V V、内含 2 .2× 10 - 3mol L的樟脑磺酸 ) ,流速为 0 .3mL min。苯丙醇胺、美托洛尔、普萘洛尔、肾上腺素和沙丁胺醇对映体的分离因子分别为 1.2 9、1.2 5、1.2 5、1.33和 1.2 9;它们的分离度分别为 1.5 5、1.78、1.83、1.89和 1. 展开更多
关键词 离子对色谱法 苯丙醇胺 美托洛尔 普萘洛尔 肾上腺素 沙丁胺醇 阿替洛尔 对映体 分离 氨基醇 Β-受体阻滞剂
在线阅读 下载PDF
手性毛细管电色谱拆分比索洛尔、阿替洛尔、克仑特罗和特布他林 被引量:12
18
作者 陈仲益 夏宗玲 +2 位作者 胡纯琦 曾苏 姚彤炜 《分析化学》 SCIE EI CAS CSCD 北大核心 2007年第2期181-186,共6页
以万古霉素(vancomycin)毛细管柱为手性分离色谱柱,采用CLC和pCEC方法,对比索洛尔、阿替洛尔、克仑特罗和特布他林进行了手性拆分研究。在CLC方法中,上述4种物质均在甲醇/异丙醇/三乙胺/冰醋酸(60/40/0.05/0.1,V/V)条件下获得最大分离,... 以万古霉素(vancomycin)毛细管柱为手性分离色谱柱,采用CLC和pCEC方法,对比索洛尔、阿替洛尔、克仑特罗和特布他林进行了手性拆分研究。在CLC方法中,上述4种物质均在甲醇/异丙醇/三乙胺/冰醋酸(60/40/0.05/0.1,V/V)条件下获得最大分离,分离度(Rs)分别为1.9、1.4、1.1和0.9。在pCEC方法中,采用极性有机模式时,Rs分别为1.9、1.4、1.5和1.5;采用反相模式时,Rs分别为2.0、1.7和1.2,而特布他林则未获分离。该方法能有效拆分比索洛尔、阿替洛尔、克仑特罗和特布他林,而且CLC、pCEC极性有机模式和pCEC反相模式之间有着较强的互补关系。 展开更多
关键词 毛细管液相色谱 加压毛细管电色谱 万古霉素 比索洛尔 阿替洛尔 克仑特罗 特布他林
暂未订购
阿替洛尔片人体相对生物利用度与生物等效性评价 被引量:8
19
作者 杨敏 陈铁锋 +3 位作者 余细勇 钱忆之 江桂芬 林曙光 《中国现代应用药学》 CAS CSCD 北大核心 2003年第4期283-286,共4页
目的 了解不同厂家生产的阿替洛尔片的药动学特性和相对生物利用度的差异。方法 用高效液相色谱法测定血中阿替洛尔浓度 ;2 0名健康志愿者采用自身对照、随机交叉方法 ,分别单次口服两个厂家的阿替洛尔片 5 0mg ,测定不同时间的血药浓... 目的 了解不同厂家生产的阿替洛尔片的药动学特性和相对生物利用度的差异。方法 用高效液相色谱法测定血中阿替洛尔浓度 ;2 0名健康志愿者采用自身对照、随机交叉方法 ,分别单次口服两个厂家的阿替洛尔片 5 0mg ,测定不同时间的血药浓度 ,用 3P97程序计算药动学参数 ,并对Cmax,Tmax和AUC0~T进行生物等效性分析。结果 两种制剂的阿替洛尔Tmax为 (2 .5± 0 .8)h (受试药 )和 (2 .8± 0 .9)h(对照药 )P >0 .0 5 ;Cmax为 (32 6 .1± 10 1.4 ) μg/L(受试药 )和 (30 1.1± 73.3) μg/L(对照药 ) ,(P >0 .0 5 ) ;AUC0~T为 (2 5 73.2± 737.6 ) μg·h/L(受试药 )和 (2 4 85 .4± 6 0 6 .9) μg·h/L(对照药 ) ,P >0 .0 5。受试药阿替洛尔片相对生物利用度为 (10 5 .5± 2 7.4 ) %。结论 两制剂的体内吸收、消除过程基本一致 ,经统计学分析 。 展开更多
关键词 阿替洛尔 高效液相色谱法 相对生物利用度 生物等效性
暂未订购
固相萃取结合HPLC测定血浆中阿替洛尔及其相对生物利用度的研究 被引量:9
20
作者 张毕奎 李焕德 +6 位作者 杨志玲 原海燕 郭军平 彭文兴 徐芳 陆安文 胡滨湘 《华西药学杂志》 CAS CSCD 2001年第4期257-259,262,共4页
目的 :建立血浆中阿替洛尔的固相萃取结合HPLC的检测方法 ;对两厂家生产的阿替洛尔片在人体内的相对生物利用度及生物等效性进行评价。方法 :血样采用固相萃取法处理 ,HPLC 荧光检测法测定 ,外标法定量。生物等效性以AUC0~ 36 、Cmax、... 目的 :建立血浆中阿替洛尔的固相萃取结合HPLC的检测方法 ;对两厂家生产的阿替洛尔片在人体内的相对生物利用度及生物等效性进行评价。方法 :血样采用固相萃取法处理 ,HPLC 荧光检测法测定 ,外标法定量。生物等效性以AUC0~ 36 、Cmax、Tmax为指标 ,双单侧t检验作判断。结果 :实验制剂与参比制剂的药动学参数AUC0~ 36 、Cmax、Tmax、t1/2 分别为 5 15 0 .3 5± 1172 .5 2、5 4 66.5 0± 12 77.0 8ng·h·ml 1;717.0 4± 189.69、678.63± 193 .3 6ng·ml 1;2 .4 2± 0 .4 5、2 .63± 0 .5 4h ;7.84± 1.2 5、7.73± 1.5 9h。配对t检验结果 ,两厂家产品的AUC0~ 36 、Cmax、Tmax均无显著性差异 (P >0 .0 5 )。结论 :固相萃取结合HPLC法为一种测定血浆阿替洛尔浓度较为理想的方法。两厂家产阿替洛尔片为生物等效制剂 ,试验药物对参比药物相对生物利用度为 94 .2 2 %。 展开更多
关键词 阿替洛尔 固相萃取 高效液相色谱法 药动学 相对生物利用度 降压药
暂未订购
上一页 1 2 15 下一页 到第
使用帮助 返回顶部